drugset / Trial / NCT05338047

Efficacy of Generic Pegfilgrastim vs Brand Name Pegfilrastim for Neutrophil Recovery After Autotransplant

NCT05338047 ↗

Phase 2 Completed 30 enrolled Hospital Universitario Dr. Jose E. Gonzalez
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This is a phase 2 clinical trial comparing time to neutrophil recovery after autotrasplant using generic pegfilgrastim vs brand-name pegfilgrastim.

Timeline

Start
2022-04-01
Primary completion
2023-02-25
Completion
2023-02-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pegfilgrastim Protein / enzyme biologic 6 mg Subcutaneous

Indications